8307 — Medicskin Holdings Cashflow Statement
0.000.00%
- HK$55.15m
- HK$60.60m
- HK$45.11m
Annual cashflow statement for Medicskin Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1.31 | 4.42 | -3.03 | -3.12 | -3.46 |
Depreciation | |||||
Non-Cash Items | -1.02 | -0.72 | 0.789 | 0.379 | -0.649 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.959 | -9.54 | -3.84 | 3.87 | 4.18 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 9.15 | 3.89 | 3.25 | 10.5 | 9.13 |
Capital Expenditures | -2.31 | -1.97 | -2.3 | -1.4 | -0.845 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.652 | 0.151 | -3.38 | 0 | 0.654 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.65 | -1.81 | -5.67 | -1.4 | -0.191 |
Financing Cash Flow Items | 0 | — | — | — | -0.277 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -21 | -17.5 | -6.74 | -7.21 | 1.48 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -13.5 | -15.3 | -9.16 | 1.93 | 10.4 |